Total Current Assets Total Other Assets TOTAL ASSETS Total Current Liabilities Total Liabilities Total Stockholders’ Equity Balance Balance TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Gross profit Total operating expenses Income (Loss) from operations Income (Loss) before provision for income taxes Net Income (Loss) Net income (loss) Net loss Balance (in Shares) Balance (in Shares) Equity Components [Axis] NET CASH PROVIDED BY OPERATING ACTIVITIES NET CASH USED IN INVESTING ACTIVITIES NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS - END OF PERIOD Nature of Business and Basis of Presentation [Abstract] New Accounting Standards [Abstract] Acquisitions [Abstract] Cash, Cash Equivalents and Short-Term Investments [Abstract] Revenues [Abstract] Balance Balance Deferred revenue Income Statement Location [Axis] Leases [Abstract] Total lease cost Stockholders' Equity [Abstract] Stock Based Compensation [Abstract] Earnings (Loss) Per Share [Abstract] Total Contingencies [Abstract] Income Taxes [Abstract] Subsequent Event Type [Axis] Document Type Document Quarterly Report Document Period End Date Document Fiscal Year Focus Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Amendment Flag Current Fiscal Year End Date Document Fiscal Period Focus Entity Central Index Key ASSETS Current Assets Cash and cash equivalents Short term investments Accounts receivable, net Prepaid expenses and other Property and equipment, net Other Assets Goodwill Intangible assets, net Right of use assets, net Security deposits and other assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities Accounts payable – trade Accrued expenses Revenue share payable Current portion of lease obligations Non-Current Liabilities Lease liabilities, net of current portion Commitments and contingencies (See note 10) Stockholders’ Equity Preferred stock,$0.001 par value, 10,000,000 shares authorized, none issued and outstanding at September 30, 2022 and December 31, 2021 Preferred stock, par value (in Dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, $0.001 par value, 166,666,667 shares authorized, 18,261,239 issued at September 31, 2022 and 17,860,975 shares issued and outstanding at December 31, 2021. Common stock, par value (in Dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares issued (in Shares) Common stock, shares outstanding Additional paid-in-capital Accumulated deficit Net Revenue Total Revenue Cost of revenues Operating expenses Salaries, wages, & benefits Stock-based compensation Other general and administrative expenses Other income Interest income Income tax benefit Weighted average number of shares outstanding – basic (in Shares) Weighted average number of shares outstanding – diluted (in Shares) Income (loss) per share – basic (in Dollars per share) Income (loss) per share – diluted (in Dollars per share) Shares issued for stock options exercised Shares issued for stock options exercised (in Shares) Shares issued for restricted stock units vested Shares issued for restricted stock units vested (in Shares) Stock-based compensation expense Shares issued for acquisition Shares issued for acquisition (in Shares) Repurchase of common stock (in Shares) Public offering of common shares, net of offering costs Public offering of common shares, net of offering costs (in Shares) Shares issued as board compensation Shares issued as board compensation (in Shares) CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash provided by operating activities: Depreciation and amortization Stock-based compensation Stock issued for board service Provision for loss on accounts receivable Changes in: Prepaid expenses and other assets Accounts payable Revenue share payable Accrued expenses and other liabilities Operating leases, net Deferred revenue CASH FLOWS USED IN INVESTING ACTIVITIES: CASH FLOWS PROVIDED BY FINANCING ACTIVITIES: Proceeds from public offering of common stock, net of offering costs Proceeds from exercise of stock options SUPPLEMENTAL CASH FLOW INFORMATION: Cash paid for interest Reduction of EvinceMed purchase price for amounts previously paid Shares issued in connection with acquisition Cash paid for income taxes Treasury stock Repurchase of common stock Accounts receivable Purchase of property and equipment EvinceMed acquisition Purchase of short term investments Purchase of intangible assets, including intellectual property rights Repurchase of common stock Total repurchase of common stock shares (in Dollars) Payment of contingent consideration Common Stock Common Stock [Member] Treasury Stock Additional Paid in Capital Accumulated Deficit NATURE OF BUSINESS AND BASIS OF PRESENTATION NEW ACCOUNTING STANDARDS ACQUISITIONS CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS REVENUES Schedule of deferred revenue Revenue recognized Amount collected Schedule of majority of our revenue Revenue from: LEASES Schedule of company’s lease cost Operating lease cost Short-term lease cost Schedule of future minimum lease payments 2022 2023 2024 2025 Total Less: discount Total lease liabilities STOCKHOLDERS’ EQUITY STOCK BASED COMPENSATION EARNINGS (LOSS) PER SHARE Schedule of common shares potentially Numerator Net income (loss) (in Dollars) Denominator Weighted average shares outstanding used in computing net loss per share Basic Effect of dilutive stock options, warrants, and unvested restricted stock unit awards Diluted Net income (loss) per share Basic (in Dollars per share) Diluted (in Dollars per share) Schedule of common shares potentially Weighted average number of shares for the periods ended Options Unvested restricted stock unit awards CONTINGENCIES INCOME TAXES SUBSEQUENT EVENTS Schedule of time periods Total Number of Shares Purchased Average Price Paid per Share (in Dollars per share) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Granted units (in Shares) Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs Life Science Companies [Member] Other [Member] Revenue [Member] Subsequent Event [Member] Asset Acquisition [Axis] Business Acquisition [Axis] Plan Name [Axis] Award Type [Axis] U.S. healthcare providers percentage Cash Issuance of shares of common stock (in Shares) Common stock value Previously paid amount Purchase price Total shares issued (in Shares) Shares issued (in Shares) Estimated useful life Goodwill Acquisition costs Amount held-to-maturity Fair market value Maturity dates Marketable securities Accounts receivable Deferred revenue Weighted average remaining lease term Weighted average discount rate Measurement of lease liabilities Payments on lease obligations Amortization right of use assets Common stock shares issued Received proceeds (in Dollars) Total shares issued Cashless transaction Stock options, shares Shares issued Purchase shares Repurchase of common stock shares Shares issued Gross proceeds of common stock amount (in Dollars) Issuance costs (in Dollars) Net proceeds (in Dollars) Repurchase of its outstanding common stock (in Dollars) Stock compensation recognized expense Expense remaining to be recognized related to unvested options Weighted average period Intrinsic value Shares issued (in Shares) Compensation expenses Market-based equity grants Shares valued Vesting period Vested and issued (in Shares) Restricted stock units (in Shares) Total value of vest Vest from the grant date Net operating loss carry-forwards Proceeds (in Dollars) Common stock average price Weighted average price Acquisitions [Member] EvinceMed [Member] 2013 Equity Incentive Plan [Member] 2013 equity incentive plan [Member] Equity Compensation Plan [Member] Restricted Stock Awards [Member] Equity Component [Domain] Statement [Table] Statement [Line Items] Income Statement Location [Domain] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Revenue, Major Customer [Line Items] Subsequent Event Type [Domain] Subsequent Events (Details) - Schedule of time periods [Table] Subsequent Events (Details) - Schedule of time periods [Line Items] Business Acquisition, Acquiree [Domain] Asset Acquisition [Domain] Acquisitions (Details) [Table] Acquisitions (Details) [Line Items] Plan Name [Domain] Stockholders' Equity (Details) [Table] Stockholders' Equity (Details) [Line Items] Award Type [Domain] Stock Based Compensation (Details) [Table] Stock Based Compensation (Details) [Line Items] Subsequent Events (Details) [Table] Subsequent Events (Details) [Line Items] The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Business acquisition common stock value. Cashless transaction related to expiring options. Total number of repurchased common shares. Compensation expenses. The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Effect of dilutive stock options, warrants, and stock grants. Gross proceeds of common stock amount The increase (decrease) during the reporting period in revenue share payable. Issuance of shares of common stock. Lease liabilities arising from right of use assets. Lessee operating lease liability payments due. Lessee operating leases liability undiscounted excess amount. Maturity dates. Measurement of lease liabilities. Operating leases future minimum payments due. Operating lease future minimum payments due in five years. Operating leases future minimum payments due in four years. Operating leases future minimum payments due in three years. Operating leases future minimum payments due in two years. Amount of other assets and security deposits. Provision for loss on accounts receivable. Public offering of common shares, net of offering costs. Public offering of common shares, net of offering costs shares. Purchase price. The received proceeds value. Reduction of EvinceMed purchase price for amounts previously paid. Aggregate carrying value as of the balance sheet date of the liabilities for revenue share payable within one year (or the normal operating cycle, if longer). Tabular disclosure of common shares potential. The entire tabular disclosure of schedule of future minimum rental payments for operating leases. The entire disclosure of time periods. Gross options granted during the period. Shares issued in connection with acquisitions. Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. Stock issued for board service. U.S. healthcare providers percentage. The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Revenue Share Payable Current Earnings Per Share, Basic Supplemental Cash Flow Information [Abstract] Other Nonoperating Income (Expense) Schedule Of Futures Minimum Rental Payments For Operating Leases Table Text Block Maturity Dates Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Liabilities Lessee Operating Leases Liability Payments Due Statement of Stockholders' Equity [Abstract] Deferred Revenue, by Arrangement, Disclosure [Table Text Block] Compensation Expenses Net Cash Provided by (Used in) Operating Activities [Abstract] Commitments and Contingencies Stock Issued During Period, Shares, Stock Splits Other Assets [Abstract] Entity Small Business Entity File Number Stock Issued For Board Service Entity Address, City or Town Assets [Abstract] Operating Lease, Liability, Noncurrent Operating Lease Future Minimum Payments Due In Three Years Share-Based Payment Arrangement, Expense Common Stock, Value, Issued Shares Issued, Price Per Share Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Per Share Weighted Average Price of Shares Purchased Net Cash Provided by (Used in) Financing Activities [Abstract] Weighted Average Number of Shares, Restricted Stock Entity Filer Category Weighted Average Number of Shares Outstanding, Basic Reduction Of Evince Med Purchase Price For Amounts Previously Paid Liabilities, Noncurrent Interest Paid, Excluding Capitalized Interest, Operating Activities Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Lessee Operating Leases Liability Undiscounted Excess Amount Accounts Payable, Trade, Current Stockholders' Equity Attributable to Parent [Abstract] Assets Treasury Stock, Value Stockholders' Equity Note Disclosure [Text Block] Entity Address, State or Province Subsequent Events [Text Block] Public Offering Of Common Shares Net Of Offering Costsin Shares Prepaid Expense, Current Cash and Cash Equivalents, at Carrying Value Preferred Stock, Shares Authorized Stock Issued During Period, Value, Acquisitions Local Phone Number Deferred Revenue, Current Increase (Decrease) in Operating Lease Liability Increase (Decrease) in Accounts Payable Other Intangible Assets, Net Income Tax Expense (Benefit) Stock Issued During Period, Shares, Acquisitions Income Statement [Abstract] Net Cash Provided by (Used in) Investing Activities Weighted Average Number Of Shares For The Periods Ended Abstract Entity Common Stock, Shares Outstanding Operating Lease Future Minimum Payments Due In Four Years Earnings Per Share, Diluted Lessee, Operating Leases [Text Block] Stock Issued During Period, Shares, New Issues Net Income Loss Per Share Abstract Retained Earnings [Member] Preferred Stock, Shares Issued Document Transition Report Operating Lease Future Minimum Payments Due In Two Years Unlabeled Abstract16 Marketable Securities Net Cash Provided by (Used in) Investing Activities [Abstract] Unlabeled Abstract17 Denominator Abstract Share Based Compensations Arrangement By Share Based Payment Award Options Grants In Period Payment for Contingent Consideration Liability, Financing Activities Entity Shell Company Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Common Stock [Member] Entity Incorporation, State or Country Code Security Exchange Name Common Stock, Par or Stated Value Per Share Entity Address, Address Line Two Entity Address, Address Line One Common Stock, Shares, Outstanding Component of Operating Income [Abstract] Lease Liabilities Arising From Right Of Use Assets Share-Based Payment Arrangement [Text Block] Finite-Lived Intangible Asset, Useful Life Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Unrealized Gain (Loss) on Investments Gross Proceeds Of Common Stock Amount Title of 12(b) Security Evince Med Member Additional Paid-in Capital [Member] Stock or Unit Option Plan Expense Restricted Stock [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Operating Expenses [Abstract] Payments to Acquire Property, Plant, and Equipment Issuance Of Shares Of Common Stock Property, Plant and Equipment, Net Stock Issued During Period, Shares, Restricted Stock Award, Gross Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Preferred Stock, Shares Outstanding Provision For Loss On Accounts Receivable Contract with Customer, Liability, Revenue Recognized Payments for Repurchase of Common Stock Goodwill Entity Registrant Name Short-Term Lease, Cost Operating Lease Future Minimum Payments Due In Five Years Subsequent Event [Member] Weighted Average Number Of Diluted Share Outstanding Operating Lease, Weighted Average Discount Rate, Percent Other Member City Area Code Increase (Decrease) in Operating Capital [Abstract] Shares, Issued Lease, Cost Retained Earnings (Accumulated Deficit) Share-Based Payment Arrangement [Member] Amendment Flag Stock Issued During Period, Shares, Issued for Services Life Science Companies Member Operating Income (Loss) Entity Central Index Key Unlabeled Abstract10 Unlabeled Abstract11 Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest Unlabeled Abstract14 Unlabeled Abstract15 Stock Issued During Period, Shares, Reverse Stock Splits Unlabeled Abstract12 Unlabeled Abstract13 Treasury Stock [Member] Schedule Of Time Periods Table Text Block Liabilities, Current [Abstract] Stock Issued During Period, Value, Issued for Services Depreciation, Depletion and Amortization Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Asset Acquisition, Consideration Transferred, Transaction Cost Stock Repurchased During Period, Value Legal Fees Unlabeled Abstract2 Unlabeled Abstract1 Statement of Cash Flows [Abstract] Unlabeled Abstract4 Goodwill, Gross Unlabeled Abstract3 Measurement Of Lease Liabilities Payments of Stock Issuance Costs Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares Schedule Of Time Periods Abstract Purchase Price Unlabeled Abstract0 Unlabeled Abstract9 Income Tax Disclosure [Text Block] Unlabeled Abstract6 Unlabeled Abstract5 Unlabeled Abstract8 Unlabeled Abstract7 Stock Issued During Period, Shares, Purchase of Assets Business Acquisition Common Stock Value Cash Equivalents, at Carrying Value Selling, General and Administrative Expense Liabilities and Equity [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Common Stock Repurchased Operating Lease, Cost Stock Issued During Period, Value, Stock Options Exercised USHealthcare Providers Percentage Cash and Cash Equivalents, Policy [Policy Text Block] Stock Repurchased and Retired During Period, Shares Treasury Stock, Value, Acquired, Cost Method Assets, Current [Abstract] Operating Lease, Lease Income, Lease Payments Weighted Average Number Of Share Outstanding Basic Current Fiscal Year End Date Schedule Of Common Shares Potentially Table Text Block Unlabeled Abstract Operating Lease, Weighted Average Remaining Lease Term Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Common Stock, Shares Authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Purchased for Award Money Market Funds, at Carrying Value Operating Lease, Right-of-Use Asset, Amortization Expense Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Received Proceeds Acquisition Costs, Period Cost Proceeds from Fees Received Revenue from Contract with Customer [Text Block] Earnings Per Share [Text Block] Other Assets Stockholders' Equity Attributable to Parent Gross Profit Proceeds from Stock Options Exercised Schedule Of Common Shares Potentially Abstract Salary and Wage, Excluding Cost of Good and Service Sold Operating Lease Future Minimum Payments Due Revenues Asset Acquisition [Text Block] Basicin Per Share Payments to Acquire Short-Term Investments Liabilities and Equity Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable Short-Term Investments Schedule Of Basic And Diluted Net Loss Per Share Abstract Receivables, Net, Current Weighted Average Shares Outstanding Used In Computing Net Loss Per Share Abstract Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Liabilities, Current Payments to Acquire Businesses, Net of Cash Acquired Schedule Of Majority Of Our Revenue Abstract Assets, Current Schedule Of Future Minimum Lease Payments Abstract Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Document Fiscal Year Focus Statement of Financial Position [Abstract] Schedule Of Deferred Revenue Abstract Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Entity Emerging Growth Company Revenue Benchmark [Member] Entity Tax Identification Number Entity Address, Postal Zip Code Document Type Common Stock, Shares, Issued Entity Current Reporting Status Lease, Cost [Table Text Block] Weighted Average Number of Shares Outstanding, Diluted Document Fiscal Period Focus Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Accounting Standards Update and Change in Accounting Principle [Text Block] Entity Interactive Data Current Cost of Revenue Stock Issued During Period, Value, Restricted Stock Award, Gross Proceeds from Issuance of Common Stock Two Zero One Three Equity Incentive Plan Member Accounts Receivable, after Allowance for Credit Loss, Current Additional Paid in Capital Other Assets And Deposits Securities Sold under Agreements to Repurchase, Average Amount Outstanding Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Net Income (Loss) Attributable to Parent Cashless Transaction Share-Based Payment Arrangement, Amount Capitalized Preferred Stock, Value, Issued Income Taxes Paid Document Quarterly Report Share-Based Payment Arrangement, Noncash Expense Trading Symbol Numerator Abstract Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Subsequent Events [Abstract] Deferred Tax Assets, Operating Loss Carryforwards Series of Individually Immaterial Asset Acquisitions [Member] Schedule Of Company SLease Cost Abstract Operating Lease, Right-of-Use Asset Increase Decrease In Revenue Share Payable Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Deferred Revenue Excess Stock, Shares Issued Preferred Stock, Par or Stated Value Per Share Operating Expenses Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Maximum Number of Shares Shares, Outstanding Accrued Liabilities, Current Document Period End Date Incremental Common Shares Attributable to Dilutive Effect of Written Put Options Operating Lease, Liability, Current Temporary Equity, Shares Issued Payments to Acquire Intangible Assets Equity Method Investment, Quoted Market Value Commitments and Contingencies Disclosure [Text Block] Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Effect Of Dilutive Stock Options Warrants And Stock Grants Shares Issued In Connection With Acquisitions Increase (Decrease) in Deferred Revenue Increase (Decrease) in Accounts Receivable Dilutedin Per Share Revenue From Abstract Public Offering Of Common Shares Net Of Offering Costs Stock Issued During Period Shares Restricted Stocks Award Gross